In vitro and in vivo models reveal that HMCN1 contributes to the remodeling of the podocyte cytoskeleton and the increased expression of HMCN1 in podocytes can be stimulated in response to hyperglycemia [50], which is an important risk factor of RCC [51,52]. The gene discussed is HMCN1; the disease is Hyperglycemia.